MediFind found 5 doctor with experience in Alpha-1 Antitrypsin Deficiency (AATD) near Bismarck, ND. Of these, 4 are Experienced and 1 are Advanced.
Sanford Medical Center Rehab
Bhaja Shrestha is an Intensive Care Medicine provider in Bismarck, North Dakota. Dr. Shrestha is rated as an Advanced provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Bronchitis, Lung Metastases, Emphysema, Advanced Bronchoscopy, and Gastrostomy.
Medcenter One Health Systems DME
Andreas Sarrigiannidis is an Intensive Care Medicine provider in Bismarck, North Dakota. Dr. Sarrigiannidis is rated as an Experienced provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Advanced Bronchoscopy, and Gastrostomy.
Sanford Bismarck
Haven Malish is a Pulmonary Medicine specialist and a Sleep Medicine provider in Bismarck, North Dakota. Dr. Malish is rated as an Experienced provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Obstructive Sleep Apnea, Emphysema, Bullae, Gastrostomy, and Endoscopy. Dr. Malish is currently accepting new patients.
St Alexius Medical Center
Monica Paulo is a Pulmonary Medicine provider in Bismarck, North Dakota. Dr. Paulo is rated as an Experienced provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). Her top areas of expertise are Asthma, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), and Sarcoidosis. Dr. Paulo is currently accepting new patients.
CHI St. Alexius Health Heart & Lung Clinic
Alfredo Iardino is an Intensive Care Medicine provider in Bismarck, North Dakota. Dr. Iardino is rated as an Experienced provider by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Emphysema, and Cholesterol Pneumonia.
Last Updated: 01/09/2026